Member Exclusive NEWS ROUND-UP

Cell therapy weekly: Candidate drug receives US$120M in funding for late-stage testing

Mogrify relocates to the Bio-Innovation Centre and Canadian clinics continue to provide stem cell therapies without federal approval.

Go to the profile of RegMedNet
May 23, 2019
0
0

Please sign in or register for FREE

No comments yet.